HF158K1

· HighField Biopharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HF158K1, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors [Phase 1]